↓ Skip to main content

Dove Medical Press

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
116 Mendeley
Title
Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
Published in
Therapeutics and Clinical Risk Management, June 2012
DOI 10.2147/tcrm.s30139
Pubmed ID
Authors

Viroj Wiwanitkit

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Belgium 1 <1%
Unknown 114 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 22%
Student > Bachelor 16 14%
Student > Master 10 9%
Student > Doctoral Student 8 7%
Researcher 5 4%
Other 19 16%
Unknown 32 28%
Readers by discipline Count As %
Agricultural and Biological Sciences 18 16%
Chemistry 14 12%
Pharmacology, Toxicology and Pharmaceutical Science 10 9%
Biochemistry, Genetics and Molecular Biology 9 8%
Medicine and Dentistry 8 7%
Other 18 16%
Unknown 39 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2016.
All research outputs
#8,533,995
of 25,371,288 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#60,380
of 179,218 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 11 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,218 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.